Omeros Corporation is a biopharmaceutical company based in Washington state. Its filings show it lobbies on Medicare and Medicaid rules and other health issues, especially policies affecting non-opioid treatment payments and support for rare and pediatric disease therapies, including Priority Review Vouchers. It hired The Nickles Group and reported about $110,000 in lobbying through 2026-01-15.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRETT BAKER
The latest disclosures for this client.
THE NICKLES GROUP, LLC
Q1THE NICKLES GROUP, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE NICKLES GROUP, LLC
MARY BETH SAVARY TAYLOR
THE NICKLES GROUP, LLC
THE NICKLES GROUP, LLC
Q3THE NICKLES GROUP, LLC
Q2THE NICKLES GROUP, LLC
Q1